Aortic Biological Prosthetic Valve Dysfunction Secondary to Endocarditis: Is Percutaneous Valve-in-Valve an Option?

J Cardiovasc Echogr. 2022 Jul-Sep;32(3):168-171. doi: 10.4103/jcecho.jcecho_15_22. Epub 2022 Nov 16.

Abstract

We present the case of a 69-year-old man with an aortic biological prosthetic valve. In May 2019, the patient experienced increasing dyspnea and fatigue: A diagnosis of prosthetic aortic valve dysfunction was made, leading to severe valvular insufficiency. The dysfunction of the prosthetic valve seemed to be linked to a previous infective endocarditis: after ruling out active endocarditis, the patient was treated with an off-label valve-in-valve transcatheter aortic valve implantation.

Keywords: Aortic biological prosthetic valve dysfunction; endocarditis; valve-in-valve transcatheter aortic valve implantation.

Publication types

  • Case Reports